Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab.

Saved in:
Bibliographic Details
Title: Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab.
Authors: Muto H; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan; hisanori.muto@fujita-hu.ac.jp.; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Kuzuya T; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Tachi Y; Department of Gastroenterology, Fujita Health University Okazaki Medical Center, Okazaki, Japan., Nagano Y; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Kajino Y; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Matsushita M; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Hagihara S; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Yamamoto S; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Kobayashi T; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Katano Y; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Ohmiya N; Department of Advanced Endoscopy, Fujita Health University, Toyoake, Japan., Hashimoto S; Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan., Ariga M; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Morisaki S; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Komura G; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Nakano T; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Tanaka H; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Nakaoka K; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Ohno E; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Funasaka K; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Nagasaka M; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Miyahara R; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan., Hirooka Y; Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
Source: Anticancer research [Anticancer Res] 2026 Mar; Vol. 46 (3), pp. 1609-1618.
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7530
DOI:10.21873/anticanres.18056